Underdosing of acetaminophen by parents and emergency department utilization

Ran D Goldman1, Dennis Scolnik

  • 1Pediatric Research in Emergency Therapeutics Program (PRETx), Division of Pediatric Emergency Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada; Department of Paediatrics, University of Toronto, Toronto, Ontario, Canada.

Pediatric Emergency Care
|February 6, 2004
PubMed

Insights

Many parents underdose acetaminophen for children's fever, indicating a need for better education. If fever had subsided with medication, most parents would not have visited the emergency department.

Area of Science:

  • Pediatrics
  • Pharmacology
  • Public Health

Background:

  • Fever is a frequent pediatric concern prompting medical visits.
  • Accurate administration of fever-reducing medication is crucial for effective home management.

Purpose of the Study:

  • To assess the accuracy of parental acetaminophen dosing for pediatric fever.
  • To determine if successful fever reduction at home would alter emergency department (ED) visit decisions.

Main Methods:

  • Cross-sectional study involving 248 caregivers of children with fever treated with acetaminophen.
  • Interviews were conducted to gather data on medication administration and parental decisions.

Main Results:

  • 47% of parents administered the recommended acetaminophen dose; 12% overdosed, and 41% underdosed.
  • 54% of parents reported they would not have visited the ED if fever had subsided.
  • Higher initial fever temperatures correlated with ED visits, even if fever later subsided.

Conclusions:

  • Underdosing of acetaminophen is common, suggesting knowledge gaps or misuse.
  • Many ED visits for pediatric fever may be preventable if home treatment effectively reduces temperature.
  • Factors beyond incorrect acetaminophen dosing likely influence parental decisions to seek emergency care.
Abstract

Related Concept Videos

Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
38
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
22
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
373
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
276
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
303
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.2K